The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Regulation of G1 Cell Cycle Progression: Distinguishing the Restriction Point from a Nutrient-Sensing Cell Growth Checkpoint(s)
Open accessAbstract
Most genetic changes that promote tumorigenesis involve dysregulation of G1 cell cycle progression. A key regulatory site in G1 is a growth factor-dependent restriction point (R) where cells commit to mitosis. In addition to the growth factor-dependent "R," which maps to a site about 3.5 hours after mitosis, there is another checkpoint later in G1 that is dependent on nutritional sufficiency that has also been referred to as R. However, this second site in late G1 can be distinguished both temporally and genetically from R. We are proposing that the late G1 regulatory site be more appropriately referred to as a "cell growth" checkpoint to distinguish it from R. This checkpoint, which likely has an evolutionary relationship to the yeast cell cycle checkpoint START, is regulated by signals governed by mTOR, the mammalian target of rapamycin. This review summarizes evidence that distinguishes R from the proposed cell growth checkpoint. Since both checkpoints are dysregulated in most, if not all, human cancers, distinguishing between these 2 distinct G1 regulatory checkpoints has significance for rational therapeutic strategies targeting oncogenic signals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Lodish, H. F. (1986) · Cited by 5,650
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
G 1 Events and Regulation of Cell Proliferation
Pardee, A. B. (1989) · Science · doi:10.1126/science.2683075 · Cited by 2,182
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
Shackelford, D. B., & Shaw, R. J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2676 · Cited by 1,943
TOR, a Central Controller of Cell Growth
Schmelzle, T., & Hall, M. N. (2000) · Cell · doi:10.1016/s0092-8674(00)00117-3 · Cited by 1,924
PI3K pathway alterations in cancer: variations on a theme
Yuan, T. L., & Cantley, L. C. (2008) · Oncogene · doi:10.1038/onc.2008.245 · Cited by 1,845
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690
Hartwell, L. H., Culotti, J., Pringle, J. R., & Reid, B. J. (1974) · Science · doi:10.1126/science.183.4120.46 · Cited by 1,567
A Restriction Point for Control of Normal Animal Cell Proliferation
Pardee, A. B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.4.1286 · Cited by 1,415
Fingar, D. C., & Blenis, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207542 · Cited by 1,247
The TSC1–TSC2 complex: a molecular switchboard controlling cell growth
Huang, J., & Manning, B. D. (2008) · Biochemical Journal · doi:10.1042/bj20080281 · Cited by 1,237
G1 cell-cycle control and cancer
Massagué, J. (2004) · Nature · doi:10.1038/nature03094 · Cited by 1,224
Giacinti, C., & Giordano, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209615 · Cited by 1,216
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093
Lundberg, A. S., & Weinberg, R. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.753 · Cited by 1,067
Harbour, J. W., Luo, R. X., Santi, A. D., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)81519-6 · Cited by 1,057
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
Dual control of cell growth by somatomedins and platelet-derived growth factor.
Stiles, C. D., Capone, G. T., Scher, C. D., Antoniades, H. N., Van Wyk, J. J., & Pledger, W. J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.3.1279 · Cited by 909
Fingar, D. C., Richardson, C. J., Tee, A. R., Cheatham, L., Tsou, C., & Blenis, J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.200-216.2004 · Cited by 868
Isolation of three novel human cyclins by rescue of G1 cyclin (cln) function in yeast
Lew, D. J., Dulić, V., & Reed, S. I. (1991) · Cell · doi:10.1016/0092-8674(91)90042-w · Cited by 833
Coordination of growth with cell division in the yeast
JOHNSTON, G., PRINGLE, J., & HARTWELL, L. (1977) · Experimental Cell Research · doi:10.1016/0014-4827(77)90154-9 · Cited by 827
Cyclin E Ablation in the Mouse
Geng, Y., Yu, Q., Sicinska, E., Das, M., Schneider, J. E., Bhattacharya, S., Rideout, W. M., Bronson, R. T., Gardner, H., & Sicinski, P. (2003) · Cell · doi:10.1016/s0092-8674(03)00645-7 · Cited by 660
Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family
Koff, A., Cross, F., Fisher, A., Schumacher, J., Leguellec, K., Philippe, M., & Roberts, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90044-y · Cited by 642
Jorgensen, P., Rupeš, I., Sharom, J. R., Schneper, L., Broach, J. R., & Tyers, M. (2004) · Genes & Development · doi:10.1101/gad.1228804 · Cited by 620
Enumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation
Hahn, W. C., Dessain, S. K., Brooks, M. W., King, J. E., Elenbaas, B., Sabatini, D. M., DeCaprio, J. A., & Weinberg, R. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2111-2123.2002 · Cited by 612
Cyclin E in normal and neoplastic cell cycles
Hwang, H. C., & Clurman, B. E. (2005) · Oncogene · doi:10.1038/sj.onc.1208613 · Cited by 514
Multiple levels of cyclin specificity in cell-cycle control
Bloom, J., & Cross, F. R. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2105 · Cited by 503
Mutation analysis of 24 known cancer genes in the NCI-60 cell line set
Ikediobi, O. N., Davies, H., Bignell, G., Edkins, S., Stevens, C., O'Meara, S., Santarius, T., Avis, T., Barthorpe, S., Brackenbury, L., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0433 · Cited by 440
The Restriction Point of the Cell Cycle
Blagosklonny, M. V., & Pardee, A. B. (2002) · Cell Cycle · doi:10.4161/cc.1.2.108 · Cited by 412
Multiple Ras Effector Pathways Contribute to G1Cell Cycle Progression
Gille, H., & Downward, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.22033 · Cited by 409
WEBER, J. D., RABEN, D. M., PHILLIPS, P. J., & BALDASSARE, J. J. (1997) · Biochemical Journal · doi:10.1042/bj3260061 · Cited by 406
Upstream of the mammalian target of rapamycin: do all roads pass through mTOR?
Corradetti, M. N., & Guan, K.-L. (2006) · Oncogene · doi:10.1038/sj.onc.1209885 · Cited by 386
National Cancer Institute (2020) · Definitions · doi:10.32388/f3vp5p · Cited by 383
Rheb Activates mTOR by Antagonizing Its Endogenous Inhibitor, FKBP38
Bai, X., Ma, D., Liu, A., Shen, X., Wang, Q. J., Liu, Y., & Jiang, Y. (2007) · Science · doi:10.1126/science.1147379 · Cited by 382
Amino acid regulation of TOR complex 1
Avruch, J., Long, X., Ortiz-Vega, S., Rapley, J., Papageorgiou, A., & Dai, N. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90645.2008 · Cited by 382
Activation of RalA is critical for Ras-induced tumorigenesis of human cells
Lim, K.-H., Baines, A. T., Fiordalisi, J. J., Shipitsin, M., Feig, L. A., Cox, A. D., Der, C. J., & Counter, C. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.030 · Cited by 355
What is the restriction point?
Zetterberg, A., Larsson, O., & Wiman, K. G. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80067-0 · Cited by 351
Multiple pathways regulated by the tumor suppressor PP2A in transformation
Westermarck, J., & Hahn, W. C. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.02.001 · Cited by 344
Phospholipase D in cell proliferation and cancer.
Foster, D. A., & Xu, L. (2003) · PubMed · Cited by 334
Self-citationActivation of Protein Kinase C Triggers Its Ubiquitination and Degradation
Lu, Z., Liu, D., Hornia, A., Devonish, W., Pagano, M., & Foster, D. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.839 · Cited by 334
Self-citationRegulation of mTORC1 and mTORC2 Complex Assembly by Phosphatidic Acid: Competition with Rapamycin
Toschi, A., Lee, E., Xu, L., Garcia, A., Gadir, N., & Foster, D. A. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00782-08 · Cited by 333
Self-citationChen, C.-R., Kang, Y., & Massagué, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.992 · Cited by 320
Herrera, R. E., Sah, V. P., Williams, B. O., Mäkelä, T. P., Weinberg, R. A., & Jacks, T. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2402 · Cited by 304
Translating insights from the cancer genome into clinical practice
Chin, L., & Gray, J. W. (2008) · Nature · doi:10.1038/nature06914 · Cited by 300
Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells
Parisi, T. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg482 · Cited by 264
Growth-factor-dependent mitogenesis requires two distinct phases of signalling
Jones, S. M., & Kazlauskas, A. (2001) · Nature Cell Biology · doi:10.1038/35055073 · Cited by 262
Cell cycle targets of Ras/Raf signalling
Kerkhoff, E., & Rapp, U. R. (1998) · Oncogene · doi:10.1038/sj.onc.1202185 · Cited by 260
TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G1 arrest
Petritsch, C., Beug, H., Balmain, A., & Oft, M. (2000) · Genes & Development · doi:10.1101/gad.854200 · Cited by 223
Phosphatidic acid signaling to mTOR: Signals for the survival of human cancer cells
Foster, D. A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.02.009 · Cited by 216
Self-citationTumor Promotion by Depleting Cells of Protein Kinase Cδ
Lu, Z., Hornia, A., Jiang, Y.-W., Zang, Q., Ohno, S., & Foster, D. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3418 · Cited by 207
Self-citationEzhevsky, S. A., Ho, A., Becker-Hapak, M., Davis, P. K., & Dowdy, S. F. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.14.4773-4784.2001 · Cited by 207
Specific growth response of ras-transformed embryo fibroblasts to tumour promoters
Paolo Dotto, G., Parada, L. F., & Weinberg, R. A. (1985) · Nature · doi:10.1038/318472a0 · Cited by 204
Regulation of G1 cell-cycle progression by oncogenes and tumor suppressor genes
Ho, A. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00263-5 · Cited by 192
Novel roles of Akt and mTOR in suppressing TGF‐β/ALK5‐mediated Smad3 activation
Song, K., Wang, H., Krebs, T. L., & Danielpour, D. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600917 · Cited by 185
Translational induction of the c-myc oncogene via activation of the FRAP/TOR signalling pathway
West, M. J., Stoneley, M., & Willis, A. E. (1998) · Oncogene · doi:10.1038/sj.onc.1201990 · Cited by 183
Phospholipase D1 is an effector of Rheb in the mTOR pathway
Sun, Y., Fang, Y., Yoon, M.-S., Zhang, C., Roccio, M., Zwartkruis, F. J., Armstrong, M., Brown, H. A., & Chen, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712268105 · Cited by 179
Transformation of Human and Murine Fibroblasts without Viral Oncoproteins
Boehm, J. S., Hession, M. T., Bulmer, S. E., & Hahn, W. C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6464-6474.2005 · Cited by 171
Cell cycle control and cancer.
Sherr, C. J. (2000) · PubMed · Cited by 145
Accumulation of Cyclin E Is Not a Prerequisite for Passage through the Restriction Point
Ekholm, S. V., Zickert, P., Reed, S. I., & Zetterberg, A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.9.3256-3265.2001 · Cited by 120
What's taking so long? S-phase entry from quiescence versus proliferation
Coller, H. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2223 · Cited by 116
Epidermal growth factor induces cyclin D1 in a human prostate cancer cell line
Perry, J. E., Grossmann, M. E., & Tindall, D. J. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980501)35:2<117::aid-pros5>3.0.co;2-g · Cited by 111
Exponential 3T3 cells escape in mid-G1 from their high serum requirement
Yen, A., & Pardee, A. B. (1978) · Experimental Cell Research · doi:10.1016/0014-4827(78)90068-x · Cited by 108
Donovan, J. C. H., & Slingerland, J. M. (2000) · Breast Cancer Research · doi:10.1186/bcr43 · Cited by 107
Avruch, J., Long, X., Lin, Y., Ortiz-Vega, S., Rapley, J., Papageorgiou, A., Oshiro, N., & Kikkawa, U. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370223 · Cited by 78
Garcia, A., Yang, Z., Zhao, C., Toschi, A., Fan, J., Shraibman, N., Brown, H. A., Bar‐Sagi, D., Foster, D. A., & Arbiser, J. L. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0102 · Cited by 78
Self-citationK-ras modulates the cell cycle via both positive and negative regulatory pathways
Fan, J., & Bertino, J. R. (1997) · Oncogene · doi:10.1038/sj.onc.1201105 · Cited by 75
Ras and Phosphoinositide 3-Kinase: Partners in Development and Tumorigenesis
Ramjaun, A. R., & Downward, J. (2007) · Cell Cycle · doi:10.4161/cc.6.23.4996 · Cited by 72
Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-Ras
Shi, M., Yang, Z., Garcia, A., Xu, L., & Foster, D. A. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.09.003 · Cited by 69
Self-citationDefective TGF-β signaling sensitizes human cancer cells to rapamycin
Gadir, N., Jackson, D. N., Lee, E., & Foster, D. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210721 · Cited by 66
Self-citationMartinsson, H.-S., Starborg, M., Erlandsson, F., & Zetterberg, A. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.01.023 · Cited by 44
Oncogenic transformation of human cells: shortcomings of rodent model systems
Akagi, T. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.001 · Cited by 38
Genetically Engineered Human Cancer Models Utilizing Mammalian Transgene Expression
Kendall, S., Adam, S. J., & Counter, C. M. (2006) · Cell Cycle · doi:10.4161/cc.5.10.2734 · Cited by 25
Suppression TGF-β Signaling by Phospholipase D
Gadir, N., Lee, E., Garcia, A., Toschi, A., & Foster, D. A. (2007) · Cell Cycle · doi:10.4161/cc.6.22.4921 · Cited by 20
Self-citation[Can defective TGF-Beta signaling be an Achilles heel in human cancer?].
Foster, D. A., & Gadir, N. (2008) · PubMed · Cited by 4
Self-citation
Cited by
Control of cell cycle transcription during G1 and S phases
Bertoli, C., Skotheim, J. M., & de Bruin, R. A. M. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3629 · Cited by 1,500
Nanoscale surfaces for the long-term maintenance of mesenchymal stem cell phenotype and multipotency
McMurray, R. J., Gadegaard, N., Tsimbouri, P. M., Burgess, K. V., McNamara, L. E., Tare, R., Murawski, K., Kingham, E., Oreffo, R. O. C., & Dalby, M. J. (2011) · Nature Materials · doi:10.1038/nmat3058 · Cited by 779
Potassium channels in cell cycle and cell proliferation
Urrego, D., Tomczak, A. P., Zahed, F., Stühmer, W., & Pardo, L. A. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0094 · Cited by 388
Store-Operated Ca2+ Entry Controls Clonal Expansion of T Cells through Metabolic Reprogramming
Vaeth, M., Maus, M., Klein-Hessling, S., Freinkman, E., Yang, J., Eckstein, M., Cameron, S., Turvey, S. E., Serfling, E., Berberich-Siebelt, F., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.09.003 · Cited by 276
Pyruvate Kinase Isoform Expression Alters Nucleotide Synthesis to Impact Cell Proliferation
Lunt, S. Y., Muralidhar, V., Hosios, A. M., Israelsen, W. J., Gui, D. Y., Newhouse, L., Ogrodzinski, M., Hecht, V., Xu, K., Acevedo, P. N. M., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2014.10.027 · Cited by 257
Metadata
- Authors
- Foster, D. A., Yellen, P., Xu, L., & Saqcena, M.
- Venue
- Genes & Cancer
- Publisher
- SAGE Publications
- Published
- 2010-11-01
- Volume
- 1
- Issue
- 11
- Pages
- 1124-1131
- ISSN
- 1947-6019 (ISSN-L)
- 1947-6027
- OpenAlex
- W2101579411
- Cited by
- 275
- References
- 81
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.